Outcomes of hematopoietic stem cell transplant patients who received continuous renal replacement therapy in a pediatric oncology intensive care unit

Pediatric Critical Care Medicine

Volumn 11, Issue 6, 2010, Pages 699-706

  Rajasekaran, Surender ^a   Jones, Deborah P ^b   Avent, Yvonne ^a   Shaffer, Michele L ^c   Elbahlawan, Lama ^a   Henderson, Nan ^a   Barfield, Raymond C ^d   Morrison, R Ray ^a   Tamburro, Robert F ^e  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^c PENN STATE COLLEGE OF MEDICINE   (United States)

^d DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e PENN STATE CHILDREN S HOSPITAL   (United States)

Author keywords

continuous renal replacement therapy; graft vs. host disease; hematopoietic stem cell transplant; multiorgan dysfunction; pediatric oncology

Indexed keywords

BILIRUBIN; C REACTIVE PROTEIN;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BILIRUBIN BLOOD LEVEL; CHILD; CLINICAL ARTICLE; COHORT ANALYSIS; CONTINUOUS RENAL REPLACEMENT THERAPY; DEMOGRAPHY; FEMALE; HUMAN; INFANT; INFLAMMATION; INTENSIVE CARE UNIT; MALE; MULTIPLE ORGAN FAILURE; NEUTROPHIL COUNT; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SURVIVAL RATE; SURVIVAL TIME; TERTIARY HEALTH CARE; TREATMENT INDICATION; UREA NITROGEN BLOOD LEVEL;

EID: 78649498196     PISSN: 15297535     EISSN: None     Source Type: Journal    
DOI: 10.1097/PCC.0b013e3181e32423     Document Type: Article

References (38)

1. Lopes JA, Jorge S, Silva S, et al: Prognostic utility of the acute kidney injury network (AKIN) criteria for acute kidney injury in myeloablative haematopoietic cell transplantation. Bone Marrow Transplant 2007; 40: 1005-1006
2. Detaille T, Anslot C, de Cléty SC: Acute kidney injury in paediatric bone marrow patients. Acta Clin Belg Suppl 2007; 2:401-404
3. Lane PH, Mauer SM, Blazar BR, et al: Outcome of dialysis for acute renal failure in pediatric bone marrow transplant patients. Bone Marrow Transplant 1994; 13:613-617
4. Investigators RS: Renal replacement therapy for acute kidney injury in Australian and New Zealand intensive care units: A practice survey. Crit Care Resusc 2008; 10:225-230
5. DiCarlo JV, Alexander SR, Agarwal R, et al: Continuous veno-venous hemofiltration may improve survival from acute respiratory distress syndrome after bone marrow transplantation or chemotherapy. J Pediatr Hematol Oncol 2003; 25:801-805
6. Michael M, Kuehnle I, Goldstein SL: Fluid overload and acute renal failure in pediatric stem cell transplant patients. Pediatr Nephrol 2004; 19:91-95
7. Flores FX, Brophy PD, Symons JM, et al: Continuous renal replacement therapy (CRRT) after stem cell transplantation. A report from the prospective pediatric CRRT Registry Group. Pediatr Nephrol 2008; 23: 625-630
8. Bunchman TE, McBryde KD, Mottes TE, et al: Pediatric acute renal failure: outcome by modality and disease. Pediatr Nephrol 2001; 16:1067-1071
9. Foland JA, Fortenberry JD, Warshaw BL, et al: Fluid overload before continuous hemofiltration and survival in critically ill children: A retrospective analysis. Crit Care Med 2004; 32:1771-1776
10. Kist-van Holthe JE, Goedvolk CA, Brand R, et al: Prospective study of renal insufficiency after bone marrow transplantation. Pediatr Nephrol 2002; 17:1032-1037
11. Patzer L, Kentouche K, Ringelmann F, et al: Renal function following hematological stem cell transplantation in childhood. Pediatr Nephrol 2003; 18:623-635
12. Goldstein SL, Currier H, Graf C, et al: Outcome in children receiving continuous venovenous hemofiltration. Pediatrics 2001; 107: 1309-1312
13. Bernard GR, Artigas A, Brigham KL, et al: The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994; 149: 818-824 (Pubitemid 24082248)
14. Schwartz GJ, Gauthier B: A simple estimate of glomerular filtration rate in adolescent boys. J Pediatr 1985; 106:522-526
15. Bacigalupo A, Oneto R, Bruno B, et al: Early predictors of transplant-related mortality (TRM) after allogeneic bone marrow transplants (BMT): Blood urea nitrogen (BUN) and bilirubin. Bone Marrow Transplant 1999; 24:653-659
16. Sormani MP, Oneto R, Bruno B, et al: A revised day -7 predictive score for transplant- related mortality: Serum cholinesterase, total protein, blood urea nitrogen, gamma glutamyl transferase, donor type and cell dose. Bone Marrow Transplant 2003; 32: 205-211
17. Benoit G, Phan V, Duval M, et al: Fluid balance of pediatric hematopoietic stem cell transplant recipients and intensive care unit admission. Pediatr Nephrol 2007; 22: 441-447
18. Subbarao G, Haut PR, Johnson CS, et al: Incidence, etiology, and risk factors for liver dysfunction in children following hematopoietic stem cell transplantation. Pediatr Transplant 2006; 10:682-689
19. Wojnar J, Giebel S, Holowiecka-Goral A, et al: Prediction of nonrelapse mortality for patients surviving 100 days after allogeneic hematopoietic stem cell transplantation. Transplant Proc 2007; 39:3375-3379
20. Tamburro RF, Barfield RC, Shaffer ML, et al: Changes in outcomes (1996 -2004) for pediatric oncology and hematopoietic stem cell transplant patients requiring invasive mechanical ventilation. Pediatr Crit Care Med 2008; 9:270-277
21. van Gestel JP, Bollen CW, van der Tweel I, et al: Intensive care unit mortality trends in children after hematopoietic stem cell transplantation: A meta-regression analysis. Crit Care Med 2008; 36:2898-2904
22. Pene F, Aubron C, Azoulay E, et al: Outcome of critically ill allogeneic hematopoietic stem-cell transplantation recipients: A reappraisal of indications for organ failure supports. J Clin Oncol 2006; 24:643-649
23. Flanagan PG, Barnes RA: Fungal infection in the intensive care unit. J Hosp Infect 1998; 38:163-177
24. Poole CD, Conway P, Currie CJ: An evaluation of the association between C-reactive protein, the change in C-reactive protein over one year, and all-cause mortality in chronic immune-mediated inflammatory disease managed in UK general practice. Rheumatology (Oxford) 2009; 48:78-82
25. Chwals WJ, Fernandez ME, Jamie AC, et al: Detection of postoperative sepsis in infants with the use of metabolic stress monitoring. Arch Surg 1994; 129:437-442
26. Vlasselaers D, Milants I, Desmet L, et al: Intensive insulin therapy for patients in paediatric intensive care: A prospective, randomised controlled study. Lancet 2009; 373: 547-556
27. Thompson D, Pepys MB, Wood SP: The physiological structure of human C-reactive protein and its complex with phosphocholine. Structure 1999; 7:169-177
28. Wang XS, Shi Q, Williams LA, et al: Serum interleukin-6 predicts the development of multiple symptoms at nadir of allogeneic hematopoietic stem cell transplantation. Cancer 2008; 113:2102-2109
29. Steffen M, Durken M, Pichlmeier U, et al: Serum interleukin-6 levels during bone marrow transplantation: Impact on transplantrelated toxicity and engraftment. Bone Marrow Transplant 1996; 18:301-307
30. Bonig H, Schneider DT, Sprock I, et al: "Sepsis" and multi-organ failure: predictors of poor outcome after hematopoietic stem cell transplantation in children. Bone Marrow Transplant 2000; 25(Suppl 2):S32-S34
31. Schneider DT, Lemburg P, Sprock I, et al: Introduction of the oncological pediatric risk of mortality score (O-PRISM) for ICU support following stem cell transplantation in chil- dren. Bone Marrow Transplant 2000; 25: 1079-1086
32. Schneider DT, Cho J, Laws HJ, et al: Serial evaluation of the oncological pediatric risk of mortality (O-PRISM) score following allogeneic bone marrow transplantation in children. Bone Marrow Transplant 2002; 29:383-389
33. Hill GR: Inflammation and bone marrow transplantation. Biol Blood Marrow Transplant 2008; 15(1 Suppl):139-141
34. Jacobe SJ, Hassan A, Veys P, et al: Outcome of children requiring admission to an intensive care unit after bone marrow transplantation. Crit Care Med 2003; 31:1299-1305
35. Diaz MA, Vicent MG, Prudencio M, et al: Predicting factors for admission to an intensive care unit and clinical outcome in pediatric patients receiving hematopoietic stem cell transplantation. Haematologica 2002; 87:292-298
36. Toft P, Kehler D, Brandslund II, et al: The immunological effects of continuous venovenous haemodiafiltration in critically ill patients. Crit Care 1999; 3:159-165
37. DiScipio AW, Burchard KW: Continuous arteriovenous hemofiltration attenuates polymorphonuclear leukocyte phagocytosis in porcine intraabdominal sepsis. Am J Surg 1997; 173:174-180
38. Payen D, Mateo J, Cavaillon JM, et al: Impact of continuous venovenous hemofiltration on organ failure during the early phase of severe sepsis: A randomized controlled trial. Crit Care Med 2009; 37:803-810